Segment Information (Schedule of Segment Information) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Net Revenue	$ 16,528	$ 21,085	$ 59,339	$ 50,515
Direct cost of goods	(7,221)	(11,167)	(23,057)	(22,559)
Research and development	(29,902)	(28,080)	(99,755)	(85,811)
Selling, general and administrative	(30,139)	(22,221)	(85,457)	(59,145)
Wire transfer fraud loss		(9,540)		(9,540)
Other expense	(2,326)	4,062	(7,538)	30,222
Income tax expense	0	0	0	0
Net loss	(53,060)	(45,861)	(156,468)	(96,318)
Dermatology Products Sales [Member]
Segment Reporting Information [Line Items]
Net Revenue	16,116	19,610	57,703	45,617
Direct cost of goods	(7,221)	(11,167)	(23,057)	(22,559)
Research and development	(2,812)	(794)	(6,687)	(14,566)
Selling, general and administrative	(15,574)	(10,755)	(45,517)	(24,776)
Wire transfer fraud loss		(9,540)		(9,540)
Other expense	(577)	(1,375)	(1,413)	(3,120)
Net loss	(10,068)	(14,021)	(18,971)	(28,944)
Pharmaceutical and Biotechnology Product Development [Member]
Segment Reporting Information [Line Items]
Net Revenue	412	1,475	1,636	4,898
Direct cost of goods	0	0
Research and development	(27,090)	(27,286)	(93,068)	(71,245)
Selling, general and administrative	(14,565)	(11,466)	(39,940)	(34,369)
Wire transfer fraud loss		0
Other expense	(1,749)	5,437	(6,125)	33,342
Net loss	$ (42,992)	$ (31,840)	$ (137,497)	$ (67,374)